Global Implantable Infusion Pumps Market – Industry Trends and Forecast to 2030

Implantable Infusion Pumps Market Analysis and Size

Growing incidents and incidences of chronic diseases globally are essential to increased market growth. Several conditions, such as cancer, immune deficiencies, and congestive heart failure, cannot be treated with oral medications and need infusion therapy. Moreover, several companies in the implantable infusion pump market are increasingly focusing on launching smart infusion pumps, leading to the market's growth.  

Data Bridge Market Research analyses that the global implantable infusion pumps market, USD 18.26 billion in 2022, would rise to USD 27.60 billion by 2030 and is expected to undergo a CAGR of 5.30% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Implantable Infusion Pumps Market Scope and Segmentation

Market Definition

Implantable infusion pump systems, accessories, and software are medical devices used in clinics, hospitals, ambulatory centers, and home healthcare for infusing fluids and nutrients into the patient's body. These are widely used for diabetes, pain management, general infusion, anesthesia management, gastroenterology, insulin infusion, pediatrics/neonatology, and hematology.

Global Implantable Infusion Pumps Market Dynamics

Drivers

• Increasing Technological Advancements by Market Players

Several companies in the market are increasingly focusing on launching smart infusion pumps. The wide use of wireless technology in health monitoring devices is surging, which increases the ease of usage, connectivity, and data analysis. The addition of wireless technology enables the transfer of data from the device to a smartphone or a wireless device through Bluetooth or other cellular connection for data processing, which can be further used for study and to check the individual's health condition. This boosts market growth.

• Growth in Chronic Illness

Chronic illnesses and disorders are increasing worldwide as the elderly population and social behavior shifts gradually increase these diseases. In diseases such as chronic arachnoiditis, implantable infusion pumps offer lower dosages of drugs and tend to offer more efficient pain relief. The incidence of chronic diseases is anticipated to surge by 57% by 2020, as per the World Health Organization. Consequently, the demand for implantable infusion pumps is also increasing. Thus, this factor boosts market growth.

Opportunities

• Growing Rate of Acquisitions by Market Players

The increasing rate of acquisitions by market players leads to market growth. For instance, Medtronic, a U.S.-based medical device company, acquired implanted infusion pump technology from Alfred E. Mann Foundation in 2021. The acquisition was made to enhance insulin delivery in people with type-1 diabetes. Alfred E. Mann Foundation is a U.S.-based scientific research foundation launching implantable infusion pumps and other medical devices. Thus, this factor boosts market growth.  

Restraints/Challenges

• Safety Concerns Associated with Infusion Pumps

The safety concern associated with implantable infusion pumps is a major factor hindering the market's growth. The MRI setting poses a huge risk for patients with implantable infusion pumps. The U.S. food and drug administration (U.S. FDA) received evidence of major severe effects, including harm to the patient and death, regarding implantable infusion pumps in the MR field. Thus, this factor impedes market growth.

This implantable infusion pumps market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the implantable infusion pumps market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Implantable Infusion Pumps Market Scope

The implantable infusion pumps market is segmented on the basis of product type, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Piston Type Infusion Pumps
• Creeping Type Infusion Pumps
• Enteral Pump
• Elastomeric Pump
• Insulin Pump
• Syringe Pump

Application

• Cancer Treatment
• Cancer pain
• Noncancerous pain
• Mixed sarcoma
• Skin cancers
• Gastric cancer
• Spasticity
• Analgesia
• Diabetes Mellitus
• Gastroenterology
• Hematology
• Pediatrics
• Others

End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Implantable Infusion Pumps Market Regional Analysis/Insights

The implantable infusion pumps market is analyzed and market size insights and trends are provided by product type, distribution channel, and end user as referenced above.

The countries covered in the implantable infusion pumps market report are U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to grow the implantable infusion pumps market during the forecast period due to the elevated burden of chronic diseases such as cardiovascular illnesses, diabetes, and cancer. Also, decreasing treatment costs are paving the way for the infusion industry, leading to market growth.

North America dominates the market in the forecast period due to the rising adoption of specialty infusion pumps for treating chronic diseases and the increasing prevalence of chronic diseases. Also, the growing geriatric population rate and the presence of many large hospitals in the region lead to the market growth rate.  

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The implantable infusion pumps market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for implantable infusion pumps market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the implantable infusion pumps market. The data is available for historic period 2011-2021.

Competitive Landscape and Implantable Infusion Pumps Market Share Analysis

The implantable infusion pumps market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to implantable infusion pumps market.

Some of the major players operating in the implantable infusion pumps market are:

• BD (U.S.)
• B.Braun Melsungen AG (Germany)
• Medtronic (Ireland)
• Teleflex Incorporated (U.S.).
• AngioDynamics (U.S.)
• Novo Nordisk A/S (Denmark)
• Johnson and Johnson Services, Inc. (U.S.).
• Pfizer Inc.(U.S.), Baxter (U.S.)
• Smith + Nephew (U.S.)
• Hoffmann-La Roche Ltd (Switzerland)
• ZOLL Medical Corporation (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)

SKU-31162